La Jolla Pharmaceutical (LJPC)

Add to Watchlists
Create an Alert
30.14 -0.26  -0.86% NASDAQ Aug 3, 17:01 Delayed 2m USD
View Full Chart
LJPC Price Chart
View All Performance Charts

LJPC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). La Jolla Pharmaceutical is up 209.4% over the last year vs S&P 500 Total Return up 10.90%, Gilead Sciences up 31.13%, and Shire up 9.04%.


LJPC Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

La Jolla Pharmaceutical Co is a biopharmaceutical company focused on the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.

LJPC Excel Add-In Codes

  • Name: =YCI("LJPC","name")
  • Description: =YCI("LJPC","description")
  • Sector: =YCI("LJPC","sector")
  • Industry: =YCI("LJPC","industry")
  • Est. Current Fiscal Year End: =YCI("LJPC","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.